251120 — Bio-FD&C Co Balance Sheet
0.000.00%
- KR₩123bn
- KR₩79bn
- KR₩16bn
- 66
- 27
- 72
- 58
Annual balance sheet for Bio-FD&C Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,494 | 5,485 | 40,329 | 40,882 | 45,884 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 978 | 2,027 | 2,266 | 2,987 | 2,867 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,867 | 9,173 | 44,894 | 45,726 | 50,847 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,670 | 13,091 | 12,217 | 13,263 | 13,644 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 17,626 | 23,040 | 59,036 | 62,813 | 67,316 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,436 | 6,751 | 5,981 | 4,091 | 3,980 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5,202 | 7,157 | 6,058 | 4,196 | 4,184 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 12,425 | 15,883 | 52,977 | 58,617 | 63,131 |
Total Liabilities & Shareholders' Equity | 17,626 | 23,040 | 59,036 | 62,813 | 67,316 |
Total Common Shares Outstanding |